http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6314724-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df039a3bba404699e360a74b0bea24a6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 1986-07-08^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de2531fdc1d334999f13c9ce13feca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac11946b2c588bbaa772f8c06efa8600
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d04a774ff4d4acc80ebc399a561631c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6bab98906abeb5f91701768ea019f3
publicationDate 1988-01-21^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6314724-A
titleOfInvention Prazosin preparation
abstract PURPOSE: To provide the titled preparation containing crystalline prazosin and an enteric base (excluding acrylic resin). n CONSTITUTION: The objective prazosin preparation can be produced by mixing crystalline prazosin (e.g. hydrochloride: the crystal form of the compound may be α-, β- or γ-form, etc., or their mixture; preferably fine powder with an average particle diameter of ≤100μ, especially ≤30μ) and an enteric base (a pH- dependent polymeric substance capable or forming a film from an organic solvent, insoluble in water and soluble at ≥4.5 pH: e.g. cellulose acetate phthalate, shellac, etc.) at a weight ratio of 1:(0.05W50) and, if necessary, further mixing with a nonionic surfactant, excipient, disintegrant, colorant, etc. The dissolution rate of prazosin from the preparation is high and the released prazosin can be easily absorbed through digestive tracts. Prazosin is active to circulatory system (dilates peripheral vessel, decreases peripheral flow resistance and lowers pressure level) and is useful as a remedy for hypertension. n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0523588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0224121-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8980321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006500349-A
priorityDate 1986-07-08^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409343598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474

Showing number of triples: 1 to 32 of 32.